NFE2L2 and ovarian cancer: Sun et al. reported that the Nrf2/HO-1 pathway positively regulated by SIRT5 contributed to cisplatin resistance in ovarian cancer cells by suppressing cisplatin-induced DNA damage in an ROS-dependent manner [169].